In Reply
- PMID: 30681533
- DOI: 10.1097/AOG.0000000000003096
In Reply
Comment on
-
Adjuvant Use of Rifampin for Refractory Intrahepatic Cholestasis of Pregnancy.Obstet Gynecol. 2018 Sep;132(3):678-681. doi: 10.1097/AOG.0000000000002794. Obstet Gynecol. 2018. PMID: 30095766
-
Adjuvant Use of Rifampin for Refractory Intrahepatic Cholestasis of Pregnancy.Obstet Gynecol. 2019 Feb;133(2):384-385. doi: 10.1097/AOG.0000000000003095. Obstet Gynecol. 2019. PMID: 30681532 No abstract available.
References
-
- Liu J, Murray AM, Mankus EB, Ireland KE, Acosta OM, Ramsey PS. Adjuvant use of rifampin for refractory intrahepatic cholestasis of pregnancy. Obstet Gynecol 2018;132:678–1.
-
- Sibai BM, Stella CL. Diagnosis and management of atypical preeclampsia-eclampsia. Am J Obstet Gynecol 2009;200:481.e1–7.
-
- American College of Obstetricians and Gynecologists Task Force on Hypertension in Pregnancy. Hypertension in pregnancy. Washington, DC: American College of Obstetricians and Gynecologists; 2013.
-
- Williamson C, Greenes V. Intrahepatic cholestasis of pregnancy. Obstet Gynecol 2014;124:120–33.
-
- Raz Y, Lavie A, Vered Y, Goldiner I, Skornick-Rapaport A, Landberg Asher Y, et al. Severe intrahepatic cholestasis of pregnancy is a risk factor for preeclampsia in singleton and twin pregnancies. Am J Obstet Gynecol 2015;213:395.e1–8.
Publication types
MeSH terms
Substances
Supplementary concepts
LinkOut - more resources
Full Text Sources